Data from EMC - Curated by EPG Health - Last updated 16 August 2016


Co-trimoxazole should only be used where, in the judgement of the physician, the benefits of treatment outweigh any possible risks; consideration should be given to the use of a single effective antibacterial agent.

The in vitro susceptibility of bacteria to antibiotics varies geographically and with time; the local situation should always be considered when selecting antibiotic therapy.

1) Treatment and prophylaxis (primary and secondary) of Pneumocytosis jiroveci (P. carinii) in adults and children.

2) Treatment and prophylaxis of toxoplasmosis, treatment of nocardiosis.

3) Treatment of urinary tract infections and acute exacerbations of chronic bronchitis, where there is bacterial evidence of sensitivity to Co-trimoxazole and good reason to prefer this combination to a single antibiotic.

4) Treatment of acute otitis media where there is good reason to prefer Co-trimoxazole to a single antibiotic.

Full Prescribing information

Learning Zones

An Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease (COPD)

View highlights from recent congresses presented in new expert videos with leading physicians.

+ 7 more

Hereditary ATTR amyloidosis

Hereditary ATTR amyloidosis

Explore the pathophysiology, epidemiology and multi-system symptoms associated with hereditary ATTR amyloidosis, as well as how to achieve an early and accurate diagnosis.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Load more

Related Content

More information

Category Value
Orphan designation No
Type POM
Marketing authorisation holder Actavis UK Limited